Target intelligence / Profile preview

Ribosomal protein L17 pseudogene 49 (RPL17P49)

Target: RPL17P49
Molecular classification: Other

Overview

Ribosomal protein L17 pseudogene 49 (RPL17P49) is a processed pseudogene of the ribosomal protein L17 gene distributed throughout the human genome. Unlike the functional ribosomal protein L17 (RPL17), which is an essential component of the 60S ribosomal subunit and involved in protein synthesis[1][5], pseudogenes such as RPL17P49 do not encode functional proteins and lack direct biological or disease associations. They are generally considered non-functional remnants of gene duplication or retrotransposition and are not recognized as therapeutic targets or biomarkers[3][4].

Other names: RPL17_20_1764

Beyond the preview

Go deeper on Ribosomal protein L17 pseudogene 49 (RPL17P49).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L17 pseudogene 49 (RPL17P49).

Explore the full profile